Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ADP-A2M10
i
Other names:
MAGE A10 TCR, MAGEA10 TCR, ADP-A2M10, Mage-A10 TCR, MAGEA10ᶜ⁷⁹⁶T, autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells, MAGE A10-specific T-cells, MAGE A10-transduced lymphocytes, MAGE-A10 SPEAR T-cell therapy
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Adaptimmune
Drug class:
TCR modulator, MAGE-A10 inhibitor
Related drugs:
‹
afamitresgene autoleucel (3)
TAEST16001 (2)
AFNT-211 (1)
BSB-1001 (1)
IMC-C103C (1)
GSK3377794 (1)
TBI-1301 (1)
ADP-A2AFP (0)
E6 TCR (0)
E7 TCR-T (0)
FH-TCR-Tᴍsʟɴ (0)
HA-1 T TCR T Cell Immunotherapy (0)
HRYZ-T101 (0)
IMA101 (0)
IMA201 (0)
IMA203CD8 (0)
IMA401 (0)
IMA402 (0)
KIND T (0)
KITE-718 (0)
LYL132 (0)
LYL331 (0)
LioCyx-M (0)
MAGE A3 TCR (0)
MCC1 TCR (0)
N201 (0)
NT-175 (0)
NY-ESO-1 TCR (0)
NY-ESO-1 TCR-T cell therapy (0)
NeoTCR-P1 (0)
SAR444200 (0)
SCG101 (0)
T-Plex-200-A0201/204-A0201 (0)
T-cell receptor therapy (0)
TBI 1201 (0)
TSC-100 (0)
TSC-101 (0)
TSC-200-A0201 (0)
TSC-204-A0201 (0)
TSC-204-C0702 (0)
YK0901 (0)
mono TRuC-T CD70 cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
afamitresgene autoleucel (3)
TAEST16001 (2)
AFNT-211 (1)
BSB-1001 (1)
IMC-C103C (1)
GSK3377794 (1)
TBI-1301 (1)
ADP-A2AFP (0)
E6 TCR (0)
E7 TCR-T (0)
FH-TCR-Tᴍsʟɴ (0)
HA-1 T TCR T Cell Immunotherapy (0)
HRYZ-T101 (0)
IMA101 (0)
IMA201 (0)
IMA203CD8 (0)
IMA401 (0)
IMA402 (0)
KIND T (0)
KITE-718 (0)
LYL132 (0)
LYL331 (0)
LioCyx-M (0)
MAGE A3 TCR (0)
MCC1 TCR (0)
N201 (0)
NT-175 (0)
NY-ESO-1 TCR (0)
NY-ESO-1 TCR-T cell therapy (0)
NeoTCR-P1 (0)
SAR444200 (0)
SCG101 (0)
T-Plex-200-A0201/204-A0201 (0)
T-cell receptor therapy (0)
TBI 1201 (0)
TSC-100 (0)
TSC-101 (0)
TSC-200-A0201 (0)
TSC-204-A0201 (0)
TSC-204-C0702 (0)
YK0901 (0)
mono TRuC-T CD70 cell therapy (0)
multiplexed MAGEA1/PRAME TCR-T cell therapy (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
HLA-A*02 + MAGEA10 expression
Non Small Cell Lung Cancer
HLA-A*02 + MAGEA10 expression
Non Small Cell Lung Cancer
ADP-A2M10
Sensitive: C3 – Early Trials
ADP-A2M10
Sensitive
:
C3
ADP-A2M10
Sensitive: C3 – Early Trials
ADP-A2M10
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.